Global Alpha-mannosidosis Market: Leading Players Focusing on Research to Improve Quality of Life of Those Suffering from the Condition, Says TMR

Alpha-mannosidosis is a rare disease that can cause intellectual disability, skeletal abnormalities, and distinguishing facial features in an individual. Currently, the disorder has no cure. Treatment in most cases is limited to controlling the symptoms of the disorders. However, research and development activities are underway to halt the progression of the diseases. In a new report, titled “Alpha-Mannosidosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020,” Transparency Market Research (TMR) studies the opportunities for organizations researching on therapies to increase the life-expectancy of individuals suffering from this rare childhood disorder.

Read Full Report: http://www.transparencymarketresearch.com/alpha-mannosidosis-market.html

Those suffering from alpha-mannosidosis disorder experience various symptoms ranging from mild to severe. Infants diagnosed with the disorder have to deal with neurological deterioration, coupled with progression, at a rapid pace. The life-expectancy of infants diagnosed with the condition is often low. Moreover, the risk of death of the affected fetus even before birth prevails in some severe cases. A few individuals with the condition may however experience milder signs appearing later in life and progressing even slowly. Cases of alpha-mammosidosis with later-onset are known to survive into their fifties. However, laboratory diagnosis is necessary for detecting even the mildest cases.

Currently, only methods available to treat the underlying symptoms causing alpha-mannosidosis are recommended by physicians. Their main intent remains to avoid complication, thereby helping to improve an individual’s quality of life. A range of treatments are recommended based on the specific symptoms of a person. This could include prescribing antibiotics for the treatment of viral infections, speech therapy, tubes for draining fluid from the middle ear, physical therapy aiding movement, hearing aids, orthopedic aids, and classes to facilitate learning. Furthermore, the treatment require implantation of shunt near brain preventing fluid buildup.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2501

Researchers have been focusing on developing novel therapies to reduce the disease progression. Besides the encouraging regulatory policies, higher investment in the healthcare sector is promoting the market’s growth especially in emerging economies. Moreover, extensive research us conducted that could result into potential treatments. The market also sees opportunities in the introduction of novel therapies.

Alpha-mannosidosis is currently known to affect 1 per 500,000 individuals to 1 per 1,000,000 around the world. The condition is found across all races be it African, American, European, or Asian. Leading vendors operating in the market are engaged in several clinical trials, which include monotherapy products, combination products, molecular type, and route of administration.

Some of the prominent players such as Cytomedix, Inc. and Zymenex A/S are currently engaged in research for finding cure for alpha-mannosidosis. Besides these companies, investigations are also carried out by institutions and universities such as The Royal Children’s Hospital, Masonic Cancer Center, and University of Louisville.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.